Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C60H72N10O10S2 |
Molecular Weight | 1157.405 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C3=CC(=CC=C3)S(=O)(=O)N4CC[C@@]5([H])CC[C@H](N5C(=O)[C@H](C4)NC(=O)[C@H](C)NC)C(=O)NC(C6=CC=CC=C6)C7=CC=CC=C7)NC(=O)[C@H](C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9
InChI
InChIKey=AKLBERUGKZNEJY-RTEPGWBGSA-N
InChI=1S/C60H72N10O10S2/c1-39(61-3)55(71)63-49-37-67(34-32-45-28-30-51(69(45)59(49)75)57(73)65-53(41-18-9-5-10-19-41)42-20-11-6-12-21-42)81(77,78)47-26-17-27-48(36-47)82(79,80)68-35-33-46-29-31-52(70(46)60(76)50(38-68)64-56(72)40(2)62-4)58(74)66-54(43-22-13-7-14-23-43)44-24-15-8-16-25-44/h5-27,36,39-40,45-46,49-54,61-62H,28-35,37-38H2,1-4H3,(H,63,71)(H,64,72)(H,65,73)(H,66,74)/t39-,40-,45+,46+,49-,50-,51-,52-/m0/s1
Molecular Formula | C60H72N10O10S2 |
Molecular Weight | 1157.405 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:41:17 GMT 2023
by
admin
on
Sat Dec 16 13:41:17 GMT 2023
|
Record UNII |
E53VN70K2X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
E53VN70K2X
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY | |||
|
E53VN70K2X
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY | |||
|
1570231-89-8
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY | |||
|
300000020851
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY | |||
|
12430
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY | |||
|
C162535
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY | |||
|
73336238
Created by
admin on Sat Dec 16 13:41:17 GMT 2023 , Edited by admin on Sat Dec 16 13:41:17 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
APG-1387 in combination with TNF-α potently decreased NPC cell viability by inducing apoptosis in majority of NPC cell lines. Eight human IAP proteins and Smac mimetics activate caspases by antagonizing XIAP, which directly inhibits key caspase.
|
||
|
TARGET -> INHIBITOR |
APG-1387 in combination with TNF-α potently decreased NPC cell viability by inducing apoptosis in majority of NPC cell lines. Eight human IAP proteins and Smac mimetics activate caspases by antagonizing XIAP, which directly inhibits key caspase.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|